Astrana Health (ASTH) Other Operating Expenses (2010 - 2026)

Astrana Health has reported Other Operating Expenses for 17 years, with the latest figure at $874.8 million in Q1 2026.

• Quarterly Other Operating Expenses rose 57.37% year-over-year to $874.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 billion (up 59.33% YoY) and the FY2025 annual result came in at $2.9 billion, up 61.13% from the prior year.
• Other Operating Expenses held at $874.8 million in Q1 2026 per ASTH's latest filing, from $871.9 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $874.8 million in Q1 2026 and troughed at $225.1 million in Q1 2022.
• A 5-year average of $453.2 million and a median of $335.5 million in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses gained 13.91% in 2023, then jumped 112.0% in 2025.
• Over 5 years, Other Operating Expenses stood at $257.2 million in 2022, then increased by 24.02% to $319.0 million in 2023, then surged by 95.28% to $622.9 million in 2024, then surged by 39.98% to $871.9 million in 2025, then gained by 0.34% to $874.8 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $874.8 million, $871.9 million, and $874.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.